World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 28 November 2016
Main ID:  NCT02855645
Date of registration: 21/07/2016
Prospective Registration: No
Primary sponsor: China Medical University Hospital
Public title: The Effects of Trichosanthes Root on Blood Sugar in Patients With Diabetes Mellitus
Scientific title:
Date of first enrolment: July 2016
Target sample size: 60
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02855645
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 2/Phase 3
Countries of recruitment
Taiwan
Contacts
Name:     Ching-Liang Hsieh, M.D. , Ph.D
Address: 
Telephone: +886-4-22053366
Email: clhsieh@mail.cmuh.org.tw
Affiliation: 
Name:     Ching-Liang Hsieh
Address: 
Telephone:
Email:
Affiliation:  China Medical University Hospital
Name:     Ching-Liang Hsieh, professor
Address: 
Telephone: +886-4-22053366
Email: clhsieh@mail.cmuh.org.tw
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Early diagnosis Type ? Diabetic patients who Glycated hemoglobin A1c level between
7.0% and 9.0% (including) , and after three months of diet and exercise control.

2. The subject who was taking hypoglycemic drugs Metformin, the maximum total amount of
? 1500 mg / day.

3. Age ranged between 20 and 80 years (including).

Exclusion Criteria:

1. Pregnancy or breast-finding.

2. Allergy to test medicine.

3. Type I Diabetic patients.

4. Bleeding tendency.

5. The participants who suffered from serious disorders, such as congestive heart
failure, myocardial infarction, chronic obstructive pulmonary disease, renal failure,
cancer or stroke etc.

6. Irritable or anxious patients who cannot be assessed.

7. Refuse to sign the agreement.

8. The values of SGOT and SGPT levels were more than normal limit triple, or the value
of creatinine level was more than normal limit.

9. Plasm glucose(Glucose AC) level in fasting state ? 300 mg / dL.



Age minimum: 20 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Diabetes Mellitus
Intervention(s)
Drug: Placebo
Drug: Trichosanthes root
Primary Outcome(s)
Glycated hemoglobin A1c [Time Frame: Three months]
Plasma Blood Sugar [Time Frame: Three months]
Secondary Outcome(s)
Secondary ID(s)
CMUH105-REC2-052
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history